Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03418740 · ClinicalTrials.gov registry record
Neurology Measures in FA Children
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 108
- Enrollment target
NCT03418740 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 108 participants.
The verdict
NCT03418740 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
The purpose of this study is to identify ways to follow progression of Friedreich's Ataxia (FA) and be able to measure changes over time in children with FA. Participants will have biannual visits to observe how the disease progresses over time and determine the rate of progression. Funding Source- Food and Drug Administration Office of Orphan Products Development (FDA OOPD).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2017-11-20 |
| Est. Completion | 2023-02-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03418740
The ClinicalTrials.gov registry entry for NCT03418740 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03418740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03418740 about?
NCT03418740 is a clinical study titled "Neurology Measures in FA Children". The purpose of this study is to identify ways to follow progression of Friedreich's Ataxia (FA) and be able to measure changes over time in children with FA. Participants will have biannual visits to observe how the disease progresses over time and determine the rate of progression. Funding Source-...
What is the current status of trial NCT03418740?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2017-11-20. Estimated completion is 2023-02-02.
Who is sponsoring clinical trial NCT03418740?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.